Placebos: Clinical Trials

187 trials of Placebos, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

109 completed, 34 unknown, 20 terminated, 13 withdrawn. 187 Phase 2, 35 Phase 3, 19 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2187Completed 109, Unknown 34, Terminated 20, Withdrawn 13, Recruiting 5, Active not recruiting 3, Not yet recruiting 2, Suspended 1
Phase 335Completed 19, Unknown 8, Withdrawn 4, Terminated 3, Recruiting 1
Phase 119Completed 12, Unknown 4, Terminated 2, Not yet recruiting 1

Follow Placebos: new trials by email Literature Review of Placebos trials Research Report on Placebos

Trials (filtered) newest first · largest first

All 187 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis
BAT4406F, Placebos - Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS)
Phase 2 / Phase 3RecruitingBio-Thera Solutions1922025-10-262026-04-03
A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
apabetalone, Placebos - Kidney Failure, Chronic
Phase 1 / Phase 2Not yet recruitingResverlogix Corp442024-11-222023-11-15
The Effects of Metformin on Morbidity and Mortality in Elderly Patients
Metformin, Placebos - Burns
Phase 2Not yet recruitingHamilton Health Sciences Corporation2502024-11-012024-10-02
Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Methotrexate, Placebos - Vitiligo
Phase 2CompletedUniversity Hospital, Bordeaux322023-05-232026-05-22
Dexmedetomidine and HIPEC
Dexmedetomidine, Placebos - Inflammation, Cancer
Phase 2 / Phase 3UnknownUniversity of British Columbia202023-03-012022-11-03
Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease
Clenbuterol, Placebos - Pompe Disease (Late-onset)
Phase 2WithdrawnDuke University2023-01-012022-08-17
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.
HR18042 tablets, Tramadol hydrochloride SR Tablets, Placebos - Pain
Phase 2TerminatedJiangsu HengRui Medicine Co., Ltd.1102022-08-112025-06-26
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
Angiotensin 1-7, Placebos - Coronavirus, Respiratory Failure
Phase 2 / Phase 3UnknownErasme University Hospital602021-12-302021-08-02
Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)
Zoledronic Acid 5 MG in 5 ML Injection, Placebos - Neovascular Age-related Macular Degeneration
Phase 2CompletedOslo University Hospital402021-10-252024-04-05
Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair
Testosterone cypionate, Placebos - Rotator Cuff Tears
Phase 2 / Phase 3WithdrawnOrthopedic Institute, Sioux Falls, SD2021-08-012022-03-15
Benralizumab Initiated During Severe Asthma Attack
Benralizumab 30 MG/ML [Fasenra], Placebos - Asthma Attack, Asthma
Phase 2UnknownSingapore General Hospital1282021-06-022021-07-23
Study of CAD-1883 for Spinocerebellar Ataxia
CAD-1883, Placebos - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1
Phase 2WithdrawnCadent Therapeutics2021-06-012021-04-08
Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients
16mg,KB, Placebos - Sepsis
Phase 2UnknownTianjin Chasesun Pharmaceutical Co., LTD4242021-05-152024-04-10
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
Sulfasalazine, Placebos - Breast Cancer, Chronic Pain Due to Malignancy (Finding)
Phase 2CompletedUniversity of Arizona72021-05-032025-01-09
Melatonin on Clock Genes in Parkinson's Disease
Melatonin, Placebos - Parkinson Disease
Phase 2 / Phase 3WithdrawnInstituto Mexicano del Seguro Social2021-05-012020-08-04
Nitrites, Skeletal Muscle Mitochondrial Bioenergetics, and Physical Activity in Old Age
Placebos, 20mg sodium nitrite tid - Aging, Sedentary Lifestyle
Phase 2CompletedGladwin, Mark, MD642021-04-232024-10-10
Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19
Placebos, Leronlimab (700mg) - Coronavirus Disease 2019
Phase 2CompletedCytoDyn, Inc.562021-03-012024-04-11
Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects
15mg T3D-959, 30 mg T3D-959, 45 mg T3D-959 - Alzheimer Disease
Phase 2CompletedT3D Therapeutics, Inc.2502021-03-012024-07-19
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
eRapa, Placebos - Non-muscle Invasive Bladder Cancer
Phase 2Active not recruitingRobert Svatek1662021-01-252026-06-03
Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers
Placebos, Baclofen 5 mg, Baclofen 10mg - Acute Pain, Analgesia
Phase 2 / Phase 3TerminatedUniversity of Alabama at Birmingham192021-01-212026-01-07

Showing 20 of 187. Sign in to see all of them.

Conditions studied

COVID-19 (7)  ·  Non-alcoholic Fatty Liver Disease (5)  ·  Inflammation (4)  ·  Obesity (4)  ·  Acute Pain (3)  ·  Alzheimer Disease (3)  ·  Arthritis, Rheumatoid (3)  ·  Asthma (3)  ·  Breast Neoplasms (3)  ·  Depression (3)  ·  Epilepsy (3)  ·  Neoplasms (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Amyotrophic Lateral Sclerosis (2)  ·  Coronavirus Infections (2)

Sponsors

John Paul II Hospital, Krakow (3)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Jiangsu HengRui Medicine Co., Ltd. (2)  ·  Johns Hopkins Bloomberg School of Public Health (2)  ·  Johns Hopkins University (2)  ·  Mayo Clinic (2)  ·  Oslo University Hospital (2)  ·  Revimmune (2)  ·  State University of New York - Downstate Medical Center (2)  ·  Sun Yat-sen University (2)  ·  The Cleveland Clinic (2)  ·  Vanderbilt University Medical Center (2)  ·  Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA (2)  ·  Virginia Commonwealth University (2)  ·  Yale-NUS College (2)

Countries

United States (73)  ·  China (24)  ·  France (10)  ·  Canada (8)  ·  Spain (7)  ·  Czechia (6)  ·  Poland (6)  ·  Netherlands (5)  ·  Denmark (4)  ·  Germany (4)  ·  Italy (4)  ·  Mexico (4)  ·  Norway (4)  ·  Sweden (4)  ·  Switzerland (4)

Top investigators

Deven V Parmar, MD,FACP,FCP (2)  ·  James Murrough, MD, PhD (2)  ·  Paul C Cremer, M. D. (2)  ·  Aldo Sgaravatti, MD (1)  ·  Allison R Eckard, MD (1)  ·  Amanda C Palmer, PhD (1)  ·  Anat Berkovitch, resident (1)  ·  Andrew S Huhn, PhD (1)  ·  Angelique ME Spoelstra-de Man, Dr. (1)  ·  Angelo Tremblay, Ph.D (1)  ·  Anil Bhansali, DM (1)  ·  Antonio Abbate, MD, PhD (1)

Results publications

PMID 33754144, PMID 10427152, PMID 10811917, PMID 12050214, PMID 16450381, PMID 16611468, PMID 16984654, PMID 17138963, PMID 17492050, PMID 19700350, PMID 19720908, PMID 19858734, PMID 20012748, PMID 20417240, PMID 20506391, PMID 20739336, PMID 21300635, PMID 21981277, PMID 22406244, PMID 22983830, PMID 23047939, PMID 23204220, PMID 23393105, PMID 23404447, PMID 23620700, PMID 24126568, PMID 24256396, PMID 24374976, PMID 24445955, PMID 24485867, PMID 25445859, PMID 25606785, PMID 26647939, PMID 27447617, PMID 27609406, PMID 27609408, PMID 28673265, PMID 28749480, PMID 29294429, PMID 29718383, PMID 29982218, PMID 30713498, PMID 30904852, PMID 31024734, PMID 31268126, PMID 31310686, PMID 31356217, PMID 31824943, PMID 31997819, PMID 32135138

NIH funding

2018 (5), 2017 (4), 2015 (2), 2016 (2), 2004 (1), 2019 (1), K23DK106448 (1), P30CA006973 (1), P50AA012870 (1), P50CA058236 (1), R01AG051596 (1), R01AG058883 (1), R01AG061122 (1), R01CA190610 (1), R01CA252057 (1)